Mimecan in pituitary corticotroph cells may regulate ACTH secretion and the HPAA

Molecular and Cellular Endocrinology

Volumn 341, Issue 1-2, 2011, Pages 71-77

  Ma, Qin Yun ^a   Zhang, Xiao Na ^a   Jiang, He ^a   Wang, Zhi Quan ^a   Zhang, Hui Jie ^a   Xue, Li Qiong ^a   Chen, Ming Dao ^a   Song, Huai Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adrenocorticotrophic hormone (ACTH); Hypothalamo pituitary adrenal axis (HPAA); Mimecan; Pituitary corticotroph cells; Proopiomelanocortin (POMC)

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MIMECAN;

ACTH SECRETING CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CORTICOTROPIN RELEASING HORMONE RECEPTOR 1 GEEN; GENE; GENE EXPRESSION; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROOPIOMELANOCORTIN GENE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL LINE; CORTICOTROPHS; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PITUITARY GLAND; PITUITARY-ADRENAL SYSTEM; PRIMARY CELL CULTURE; PRO-OPIOMELANOCORTIN; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 79960607495     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.05.028     Document Type: Article

References (23)

1. Ameye L., Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002, 12:107R-116R.
2. Engler D., Redei E., Kola I. The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocr. Rev. 1999, 20:460-500.
3. Fernandez B., Kampmann A., Pipp F., Zimmermann R., Schaper W. Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Mol. Cell. Biochem. 2003, 246:3-11.
4. Iozzo R.V. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J. Biol. Chem. 1999, 274:18843-18846.
5. Kampmann A., Fernández B., Deindl E., Kubin T., Pipp F., Eitenmüller I., Hoefer I.E., Schaper W., Zimmermann R. The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis. Mol. Cell. Biochem. 2009, 322:15-23.
6. Katahira M., Iwasaki Y., Aoki Y., Oiso Y., Saito H. Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 1998, 139:2414-2422.
7. Kim W.K., Jung H., Kim D.H., Kim E.Y., Chung J.W., Cho Y.S., Park S.G., Park B.C., Ko Y., Bae K.H., Lee S.C. Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes. J. Cell Sci. 2009, 122:4160-4167.
8. Kresse H., Schonherr E. Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 2001, 189:266-274.
9. Kuchenbauer F., Hopfner U., Stalla J., Arzt E., Stalla G.K., Paez-Pereda M. Extracellular matrix components regulate ACTH production and proliferation in corticotroph tumor cells. Mol. Cell. Endocrinol. 2001, 175:141-148.
10. Long C.J., Roth M.R., Tashevam E.S., Funderburgh M., Smit R., Conrad G.W., Funderburgh J.L. Fibroblast growth factor-2 promotes keratan sulfate proteoglycan expression by keratocytes in vitro. J. Biol. Chem. 2000, 275:13918-13923.
11. Lovejoy D.A., Balment R.J. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. Gen. Comp. Endocrinol. 1999, 115:1-22.
12. Ma Q.Y., Zuo C.L., Ma J.H., Zhang X.N., Ru Y., Li P., Pan C.M., Liu Z., Cao H.M., Chen M.D., Song H.D. Glucocorticoid up-regulates mimecan expression in corticotroph cells. Mol. Cell. Endocrinol. 2010, 321:239-244.
13. Madisen L., Neubauer M., Plowman G., Rosen D., Segarini P., Dasch J., Thompson A., Ziman J., Bentz H., Purchio A.F. Molecular cloning of a novel bone-forming compound: osteoinductive factor. DNA Cell Biol. 1990, 9:303-309.
14. Papadimitriou A., Priftis K.N. Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation 2009, 16:265-271.
15. Petretto E., Sarwar R., Grieve I., Lu H., Kumaran M.K., Muckett P.J., Mangion J., Schroen B., Benson M., Punjabi P.P., Prasad S.K., Pennell D.J., Kiesewetter C., Tasheva E.S., Corpuz L.M., Webb M.D., Conrad G.W., Kurtz T.W., Kren V., Fischer J., Hubner N., Pinto Y.M., Pravenec M., Aitman T.J., Cook S.A. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat. Genet. 2008, 40:546-552.
16. Ray D., Melmed S. Pituitary cytokine and growth factor expression and action. Endocr. Rev. 1997, 18:206-228.
17. Shanahan C.M., Cary N.R., Osbourn J.K., Weissberg P.L. Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2437-2447.
18. Tasheva E.S. Analysis of the promoter region of human mimecan gene. Biochim. Biophys. Acta 2002, 1575:123-129.
19. Tasheva E.S., Maki C.G., Conrad A.H., Conrad G.W. Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. Biochim. Biophys. Acta 2001, 1517:333-338.
20. Tasheva E.S., Koester A., Paulsen A.Q., Garrett A.S., Boyle D.L., Davidson H.J., Song M., Fox N., Conrad G.W. Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol. Vis. 2002, 8:407-415.
21. Taylor A.D., Christian H.C., Morris J.F., Flower R.J., Buckingham J.C. An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. Endocrinology 1997, 138:2909-2918.
22. Tierney T., Christian H.C., Morris J.F., Solito E., Buckingham J.C. Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. J. Neuroendocrinol. 2003, 15:1134-1143.
23. Wang Y., Ma Y., Lu B., Xu E., Huang Q., Lai M. Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study. Exp. Biol. Med. (Maywood) 2007, 232:1152-1159.